Search

everythinglearnresearchcommunity

for

Search:↓

Too much androgen can cause hair loss; finasteride may help.

High testosterone to epitestosterone ratio in hair could predict male-pattern baldness.

Too much AKR1C3 enzyme causes resistance to finasteride by increasing testosterone.

The testosterone patch and gel are both effective, but they have different absorption patterns and effects on hormone levels.

Dihydrotestosterone increases certain inflammatory signals in skin cells, potentially contributing to acne.

Prenatal stress changes how male and female rats enjoy rewards differently, linked to sex hormones.

The rat model showed early perimenopause with regular cycles and low hormones, and late perimenopause with irregular cycles and higher hormone levels.

Finasteride caused enlarged breast tissue in a 62-year-old man.

Some plant-based chemicals may help with hair growth, but more research is needed to confirm their effectiveness.

Scale created to measure hair loss in men and women; MK-386 reduces acne; Niaspan treats dyslipidemia; minoxidil increases heart rate.

Triple Hormonal Blockade (ADT3) can effectively manage prostate cancer but requires careful monitoring for heart risks.

Hormonal interactions, especially involving DHT and estrogen, play a key role in BPH development and treatment.

Using two drugs together, Flutamide and 4-MA, is more effective for blocking male hormones than using each one alone.

Ficus carica extract improved fertility in rats and may help with certain health conditions.

Antiandrogens can treat female hormonal conditions, but environmental ones may harm reproductive health.

Isotretinoin and tazarotene help treat acne, while minoxidil and finasteride promote hair growth.

Longer TA repeats in the SRD5A2 gene may increase acne risk in Chinese people.

Hormonal treatment is effective for women with acne not helped by usual treatments, especially if they have hormonal imbalances.

The medications 5α-reductase inhibitors and spironolactone are generally safe for breast cancer patients on endocrine therapies and do not significantly increase breast cancer risk.

Diagnosing and treating PCOS is complex due to differing criteria and requires a team approach.

Recent hair loss research shows some progress, especially in understanding male pattern baldness, but effective treatments for many types of hair loss are still lacking.

Finasteride safely treats hair loss without harming hormones or reproduction, but may slightly reduce sexual function.

Some treatments for hereditary hair loss are effective but vary in results and side effects; new therapies show promise but need more research.

Hair loss, known as Androgenetic Alopecia, is often caused by hormones and can be diagnosed using noninvasive techniques. Treatments include topical minoxidil and oral finasteride, with new treatments being explored. There may also be a link between this type of hair loss and heart disease risk.

Finasteride changes hormone levels and certain proteins in rats, but these effects can be reversed after stopping the drug.

Two drugs, finasteride and minoxidil, are approved for hair loss treatment, but new therapies are being developed.

5α-reductase inhibitors help shrink the prostate, improve urinary symptoms, and may reduce prostate cancer risk.

Dutasteride and finasteride cause kidney damage, with dutasteride being more harmful.

Resveratrol helps prevent finasteride-induced damage in male rats, improving reproductive function.

Men with thinner hair from genetic hair loss may be more likely to have an enlarged prostate.